FI950888A - Menetelmä K-vitamiinista riippuvaisten proteiinien eristämiseksi ja puhdistamiseksi - Google Patents

Menetelmä K-vitamiinista riippuvaisten proteiinien eristämiseksi ja puhdistamiseksi Download PDF

Info

Publication number
FI950888A
FI950888A FI950888A FI950888A FI950888A FI 950888 A FI950888 A FI 950888A FI 950888 A FI950888 A FI 950888A FI 950888 A FI950888 A FI 950888A FI 950888 A FI950888 A FI 950888A
Authority
FI
Finland
Prior art keywords
isolating
vitamin
dependent proteins
proteins
dependent
Prior art date
Application number
FI950888A
Other languages
English (en)
Swedish (sv)
Other versions
FI950888A0 (fi
FI116526B (fi
Inventor
Bernhard Fischer
Artur Mitterer
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI950888A0 publication Critical patent/FI950888A0/fi
Publication of FI950888A publication Critical patent/FI950888A/fi
Application granted granted Critical
Publication of FI116526B publication Critical patent/FI116526B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI950888A 1994-02-28 1995-02-27 Menetelmä K-vitamiinista riippuvaisten proteiinien eristämiseksi ja puhdistamiseksi FI116526B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4406515A DE4406515C1 (de) 1994-02-28 1994-02-28 Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
DE4406515 1994-02-28

Publications (3)

Publication Number Publication Date
FI950888A0 FI950888A0 (fi) 1995-02-27
FI950888A true FI950888A (fi) 1995-08-29
FI116526B FI116526B (fi) 2005-12-15

Family

ID=6511421

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950888A FI116526B (fi) 1994-02-28 1995-02-27 Menetelmä K-vitamiinista riippuvaisten proteiinien eristämiseksi ja puhdistamiseksi

Country Status (13)

Country Link
US (1) US5633350A (fi)
EP (1) EP0669342B1 (fi)
JP (1) JPH07258286A (fi)
AT (1) ATE205218T1 (fi)
CA (1) CA2143510C (fi)
CZ (1) CZ290471B6 (fi)
DE (1) DE4406515C1 (fi)
DK (1) DK0669342T3 (fi)
ES (1) ES2161790T3 (fi)
FI (1) FI116526B (fi)
HU (1) HU219828B (fi)
NO (1) NO322372B1 (fi)
SK (1) SK22695A3 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245824T3 (es) * 1998-04-15 2006-01-16 Novo Nordisk A/S Nuevo proceso de separacion de proteinas utilizando un eluyente que contiene ca++.
US6869934B2 (en) * 2000-07-21 2005-03-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method of purifying calcium ion-binding protein
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
EP1831242B1 (en) * 2004-12-23 2012-09-26 Novo Nordisk Health Care AG Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
US20090047723A1 (en) * 2005-01-14 2009-02-19 Bayer Healthcare Llc Method for purification of factor vii
RU2440810C2 (ru) * 2005-04-28 2012-01-27 Ново Нордиск Хелс Кеа Аг Закрытый контейнер, содержащий активированный полипептид фактора vii, способы его получения и набор и способ применения набора
EP1991257B1 (en) 2006-03-07 2015-05-06 Baxter International Inc. Highly phosphorylated and sulfated recombinant factor ix
EP2125866B1 (en) * 2007-02-28 2013-05-22 Baxter International Inc. Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules
US9896677B2 (en) 2010-01-18 2018-02-20 Novo Nordisk Health Care Ag Purification of blood coagulation factors
NZ603289A (en) 2010-04-29 2014-07-25 Baxter Int Purification method for divalent cation binding proteins on anion exchange resin
KR20140007377A (ko) 2011-02-01 2014-01-17 노보 노르디스크 에이/에스 인슐린의 정제
LT2748179T (lt) * 2011-10-14 2022-04-11 Takeda Pharmaceutical Company Limited Baltymų gryninimas anijonų mainų chromatografija
WO2013053888A1 (en) 2011-10-14 2013-04-18 Baxter International Inc. Protein purification by anion exchange chromatography
DK2970376T3 (en) * 2013-03-15 2018-07-02 Baxalta Inc PURIFICATION PROCEDURE FOR VITAMIN K-DEPENDENT PROTEINS BY ANION EXCHANGE CHROMATOGRAPHY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
AT395596B (de) * 1991-06-20 1993-01-25 Immuno Ag Verfahren zur herstellung von aktiviertem protein c

Also Published As

Publication number Publication date
CA2143510C (en) 1999-12-21
ATE205218T1 (de) 2001-09-15
FI950888A0 (fi) 1995-02-27
EP0669342A2 (de) 1995-08-30
DK0669342T3 (da) 2001-11-12
JPH07258286A (ja) 1995-10-09
SK22695A3 (en) 1995-09-13
CA2143510A1 (en) 1995-08-29
FI116526B (fi) 2005-12-15
NO950733D0 (no) 1995-02-27
EP0669342A3 (de) 1997-04-16
NO322372B1 (no) 2006-09-25
HU9500594D0 (en) 1995-04-28
HU219828B (hu) 2001-08-28
EP0669342B1 (de) 2001-09-05
US5633350A (en) 1997-05-27
NO950733L (no) 1995-08-29
ES2161790T3 (es) 2001-12-16
CZ53995A3 (en) 1995-09-13
DE4406515C1 (de) 1995-10-19
CZ290471B6 (cs) 2002-07-17
HUT72844A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
FI950888A0 (fi) Menetelmä K-vitamiinista riippuvaisten proteiinien eristämiseksi ja puhdistamiseksi
FR2580947B1 (fr) Procede et installation d'epuration par adsorption sur charbon actif, et pot adsorbeur correspondant
DE3586944D1 (de) Vorrichtung zum abtrennen von halbleiterscheiben.
DK98186A (da) Stoevfri, enzymholdige partikler og fremgangsmaade til fremstilling deraf
IT8819945A0 (it) Sistema elaboratore avente indirizzamento indipendente dal modo di indirizzamento usato dai programmi.
IT8523140A0 (it) Assale semi rigido per veicolo.
NZ217185A (en) Alleviating cytopathic effects of htlv-iii virus on cells; pharmaceutical composition
DE3668141D1 (de) Radaufhaengung.
DK219783A (da) Zeolit og fremgangsmaade til fremstilling deraf
DE3578266D1 (de) Verfahren zum herstellen von halbleiteranordnungen und dadurch hergestellte anordnungen.
MX163470B (es) Metodo para producir aglomerados no horneados
FR2522680B1 (fr) Oxydase d'acide l-glutamique (productrice de h2o2), sa production et methode d'analyse l'utilisant
FI925550A0 (fi) Piperidylmetyl-substituerade kromanderivat
DE3466392D1 (de) Imidazoquinazoline compound
KR890004983A (ko) 실리카겔 입자의 제조 방법
FR2563829B1 (fr) Procede de production de n-(4-(3-aminopropyl)aminobutyl)-2,2-dihydroxyethanamide
TR23890A (tr) Saf asit borik üretimine mahsus usul.
FI860247A (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
AU1239495A (en) An electrophoretic method to assess human cerebrospinal fluid
FI885906A (fi) Icke-smetande dithranolkomposition.
KR870700627A (ko) 세팔로스포린 유도체의 신규 제조방법
DE3382123D1 (de) Halbleiteranordnung und herstellungsverfahren.
FR2587827B1 (fr) Procede de fabrication d'un hauban isolant et hauban realise selon le procede
FI864736A (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.
IT8384959A0 (it) Dispositivo atto all'ottenimento di una coppia motrice ausiliaria,applicabile preferibilmente su corone di trazione di bicicli o similari

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116526

Country of ref document: FI

MM Patent lapsed